| Dr Elanagan Nagarajan, MD | |
|
1 Hospital Dr, Columbia, MO 65201-5276 | |
| (573) 882-1515 | |
| (573) 884-4249 |
| Full Name | Dr Elanagan Nagarajan |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 10 Years |
| Location | 1 Hospital Dr, Columbia, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467832600 | NPI | - | NPPES |
| MISSOURI TEMP LICENS | Other | MO | 2015014077 |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 09/10/1987 (ZZ) | Secondary |
| 2084N0400X | Psychiatry & Neurology - Neurology | 2015014077 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Erlanger Medical Center | Chattanooga, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chattanooga Hamilton County Hospital Authority | 0547179731 | 156 |
| Erlanger Health | 1153780226 | 352 |
News Archive
Top naval leaders met with representatives from some of the nation's most cutting-edge small businesses this week at the Navy Opportunity Forum in Crystal City, Va., with the goal of discovering new technologies and capabilities for America's Sailors and Marines.
The Food and Drug Administration today alerted parents and caregivers that some liquid Vitamin D supplement products are sold with droppers that could allow excessive dosing of Vitamin D to infants.
Researchers have developed a new urine test to diagnose aggressive forms of prostate cancer, which could mean an end to the unnecessary treatment of men with non-aggressive cancers.
Clinicians currently lack advance warning of acute kidney injury (AKI) for patients where kidney injury timing is unknown.
Scientists from Virginia Commonwealth University Massey Cancer Center have provided evidence from preclinical experiments that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) could be used as a therapeutic target to kill bladder cancer cells, help prevent metastasis and even be used to non-invasively diagnose the disease and monitor its progression.
› Verified 4 days ago
| Entity Name | Chattanooga Hamilton County Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154751931 PECOS PAC ID: 0547179731 Enrollment ID: O20040302001086 |
News Archive
Top naval leaders met with representatives from some of the nation's most cutting-edge small businesses this week at the Navy Opportunity Forum in Crystal City, Va., with the goal of discovering new technologies and capabilities for America's Sailors and Marines.
The Food and Drug Administration today alerted parents and caregivers that some liquid Vitamin D supplement products are sold with droppers that could allow excessive dosing of Vitamin D to infants.
Researchers have developed a new urine test to diagnose aggressive forms of prostate cancer, which could mean an end to the unnecessary treatment of men with non-aggressive cancers.
Clinicians currently lack advance warning of acute kidney injury (AKI) for patients where kidney injury timing is unknown.
Scientists from Virginia Commonwealth University Massey Cancer Center have provided evidence from preclinical experiments that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) could be used as a therapeutic target to kill bladder cancer cells, help prevent metastasis and even be used to non-invasively diagnose the disease and monitor its progression.
› Verified 4 days ago
| Entity Name | Erlanger Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477256303 PECOS PAC ID: 1153780226 Enrollment ID: O20230707000849 |
News Archive
Top naval leaders met with representatives from some of the nation's most cutting-edge small businesses this week at the Navy Opportunity Forum in Crystal City, Va., with the goal of discovering new technologies and capabilities for America's Sailors and Marines.
The Food and Drug Administration today alerted parents and caregivers that some liquid Vitamin D supplement products are sold with droppers that could allow excessive dosing of Vitamin D to infants.
Researchers have developed a new urine test to diagnose aggressive forms of prostate cancer, which could mean an end to the unnecessary treatment of men with non-aggressive cancers.
Clinicians currently lack advance warning of acute kidney injury (AKI) for patients where kidney injury timing is unknown.
Scientists from Virginia Commonwealth University Massey Cancer Center have provided evidence from preclinical experiments that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) could be used as a therapeutic target to kill bladder cancer cells, help prevent metastasis and even be used to non-invasively diagnose the disease and monitor its progression.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elanagan Nagarajan, MD 1 Hospital Dr, Columbia, MO 65201-5276 Ph: (573) 882-1515 | Dr Elanagan Nagarajan, MD 1 Hospital Dr, Columbia, MO 65201-5276 Ph: (573) 882-1515 |
News Archive
Top naval leaders met with representatives from some of the nation's most cutting-edge small businesses this week at the Navy Opportunity Forum in Crystal City, Va., with the goal of discovering new technologies and capabilities for America's Sailors and Marines.
The Food and Drug Administration today alerted parents and caregivers that some liquid Vitamin D supplement products are sold with droppers that could allow excessive dosing of Vitamin D to infants.
Researchers have developed a new urine test to diagnose aggressive forms of prostate cancer, which could mean an end to the unnecessary treatment of men with non-aggressive cancers.
Clinicians currently lack advance warning of acute kidney injury (AKI) for patients where kidney injury timing is unknown.
Scientists from Virginia Commonwealth University Massey Cancer Center have provided evidence from preclinical experiments that a gene known as melanoma differentiation associated gene-9/syntenin (mda-9/syntenin) could be used as a therapeutic target to kill bladder cancer cells, help prevent metastasis and even be used to non-invasively diagnose the disease and monitor its progression.
› Verified 4 days ago
Dr. Anasseril E Daniel, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 33 E Broadway Ste 115, Columbia, MO 65203 Phone: 573-443-6930 Fax: 573-875-4272 | |
Dr. Joseph J. Parks, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Family Health Center Of Boone County, 1001 West Worley, Columbia, MO 35203 Phone: 573-214-2314 Fax: 573-814-2784 | |
Dr. Robert Edward Frazier, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 367 Crown Pt, Columbia, MO 65203 Phone: 573-442-4346 Fax: 573-443-2027 | |
Myles Brandon Goble, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 525 N. Keene Street, Suite 301, Columbia, MO 65201 Phone: 573-882-2260 Fax: 573-884-4249 | |
Ashutosh Pandey, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1020 Hitt St, Columbia, MO 65212 Phone: 573-882-1515 | |
Jeffrey Thiele, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 800 Hospital Dr, Columbia, MO 65201 Phone: 573-814-6000 | |
Lisa A Lacey, D.O. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 800 Hospital Dr, Columbia, MO 65201 Phone: 573-814-6480 |